Apellis Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US03753U1060
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityAPLS / Apellis Pharmaceuticals, Inc.
InstitutionSimplex Trading, Llc
Latest Disclosed Ownership2,735 shares
Latest Disclosed Value $ 110,029
Simplex Trading, Llc ownership in APLS / Apellis Pharmaceuticals, Inc.

On May 14, 2026 - Simplex Trading, Llc filed a 13F-HR form disclosing ownership of 2,735 shares of Apellis Pharmaceuticals, Inc. (US:APLS) valued at $110,029 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 27,187 shares of Apellis Pharmaceuticals, Inc.. This represents a change in shares of -89.94% during the quarter. The current value of the position is $112,217 USD.

Simplex Trading, Llc has a history of taking positions in derivatives of the underlying security (APLS) in the form of stock options. The firm currently holds call options representing 77,000 of underlying shares valued at $3,097,710 USD and put options representing 6,800 of underlying shares valued at $273,564 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

APLS / Apellis Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 2,735 -24,452 -89.94 110 -83.87 0.0000
2026-02-11 2025-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 27,187 -26,714 -49.56 683 68,100.00 0.0004
2025-11-12 2025-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 53,901 -2,033 -3.63 1 0.0006
2025-08-05 2025-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 55,934 55,934 1 0.0006
2025-02-11 2024-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 0 -73,982 -100.00 0 -100.00
2024-11-08 2024-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 73,982 3,910 5.58 2 0.00 0.0013
2024-07-25 2024-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 70,072 70,072 3 0.0017
2024-04-25 2024-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 0 -44,954 -100.00 0 -100.00
2024-02-02 2023-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 44,954 -31,911 -41.52 3 0.00 0.0017
2023-11-01 2023-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 76,865 854 1.12 3 -66.67 0.0023
2023-08-04 2023-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 76,011 72,588 2,120.60 7 0.0057
2023-04-27 2023-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 3,423 3,423 0 0.0002
2023-02-02 2022-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 0 -29,627 -100.00 0 -100.00
2022-11-04 2022-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 29,627 19,463 191.49 2,023 340.74 0.0023
2022-08-03 2022-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 10,164 7,197 242.57 459 206.00 0.0005
2022-05-02 2022-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 2,967 2,967 150 0.0001
2021-04-26 2021-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 0 -1,456 -100.00 0 0.0000
2021-02-02 2020-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 1,456 -2,808 -65.85 0 0.0000
2020-10-14 2020-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 4,264 -261 -5.77 0 -100.00
2020-07-13 2020-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 4,525 -1,429 -24.00 147 -7.55 0.0002
2020-04-29 2020-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 5,954 5,954 31.58 159 8.16 0.0003
2020-02-05 2019-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 0 -2,489 -100.00 0 -100.00
2019-10-15 2019-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 2,489 2,414 3,218.67 59 5,800.00 0.0002
2019-07-26 2019-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 75 75 1 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F APELLIS PHARMACEUTICALS CALL Call 77,000 -65.88 3,098 -45.37 n/a n/a n/a
2026-02-11 2025-12-31 13F APELLIS PHARMACEUTICALS CALL Call 225,700 51.37 5,670 188,866.67 n/a n/a n/a
2025-11-12 2025-09-30 13F APELLIS PHARMACEUTICALS CALL Call 149,100 3.47 3 50.00 n/a n/a n/a
2025-08-05 2025-06-30 13F APELLIS PHARMACEUTICALS CALL Call 144,100 87.39 2 100.00 n/a n/a n/a
2025-05-12 2025-03-31 13F APELLIS PHARMACEUTICALS CALL Call 76,900 -76.10 2 -90.00 n/a n/a n/a
2025-02-11 2024-12-31 13F APELLIS PHARMACEUTICALS CALL Call 321,700 26.80 10 42.86 n/a n/a n/a
2024-11-08 2024-09-30 13F APELLIS PHARMACEUTICALS CALL Call 253,700 -1.32 7 -22.22 n/a n/a n/a
2024-07-25 2024-06-30 13F APELLIS PHARMACEUTICALS CALL Call 257,100 134.79 10 50.00 n/a n/a n/a
2024-04-25 2024-03-31 13F APELLIS PHARMACEUTICALS CALL Call 109,500 -67.85 6 -70.00 n/a n/a n/a
2024-02-02 2023-12-31 13F APELLIS PHARMACEUTICALS CALL Call 340,600 -34.40 20 5.26 n/a n/a n/a
2023-11-01 2023-09-30 13F APELLIS PHARMACEUTICALS CALL Call 519,200 198.05 20 26.67 n/a n/a n/a
2023-08-04 2023-06-30 13F APELLIS PHARMACEUTICALS CALL Call 174,200 -2.24 16 36.36 n/a n/a n/a
2023-04-27 2023-03-31 13F APELLIS PHARMACEUTICALS CALL Call 178,200 18.41 12 57.14 n/a n/a n/a
2023-02-02 2022-12-31 13F APELLIS PHARMACEUTICALS CALL Call 150,500 709.14 8 -99.45 n/a n/a n/a
2022-11-04 2022-09-30 13F APELLIS PHARMACEUTICALS CALL Call 18,600 -58.39 1,270 -37.16 n/a n/a n/a
2022-08-03 2022-06-30 13F APELLIS PHARMACEUTICALS CALL Call 44,700 1.59 2,021 -9.57 n/a n/a n/a
2022-05-02 2022-03-31 13F APELLIS PHARMACEUTICALS CALL Call 44,000 1,366.67 2,235 1,485.11 n/a n/a n/a
2022-02-23 2021-12-31 13F/A APELLIS PHARMACEUTICALS CALL Call 3,000 -82.76 141 -88.04 n/a n/a n/a
2022-02-04 2021-12-31 13F APELLIS PHARMACEUTICALS CALL Call 17,400 1,179 n/a n/a n/a
2021-10-28 2021-09-30 13F APELLIS PHARMACEUTICALS CALL Call 17,400 8.75 1,179 16.62 n/a n/a n/a
2021-08-12 2021-06-30 13F APELLIS PHARMACEUTICALS CALL Call 16,000 9,042.86 1,011 34.80 n/a n/a n/a
2021-04-26 2021-03-31 13F APELLIS PHARMACEUTICALS CALL Call 175 -62.92 750 -25.82 n/a n/a n/a
2021-02-02 2020-12-31 13F APELLIS PHARMACEUTICALS CALL Call 472 59.46 0 -100.00 n/a n/a n/a
2020-10-14 2020-09-30 13F APELLIS PHARMACEUTICALS CALL Call 296 -25.25 0 -100.00 n/a n/a n/a
2020-07-13 2020-06-30 13F APELLIS PHARMACEUTICALS CALL Call 396 414.29 1,293 527.67 n/a n/a n/a
2020-04-29 2020-03-31 13F APELLIS PHARMACEUTICALS CALL Call 77 -74.42 206 -77.63 n/a n/a n/a
2020-02-05 2019-12-31 13F APELLIS PHARMACEUTICALS CALL Call 301 3,244.44 921 4,285.71 n/a n/a n/a
2019-10-15 2019-09-30 13F APELLIS PHARMACEUTICALS CALL Call 9 350.00 21 320.00 n/a n/a n/a
2019-07-26 2019-06-30 13F APELLIS PHARMACEUTICALS CALL Call 2 5 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F APELLIS PHARMACEUTICALS PUT Put 6,800 -84.65 274 -75.45 n/a n/a n/a
2026-02-11 2025-12-31 13F APELLIS PHARMACEUTICALS PUT Put 44,300 -0.23 1,113 111,100.00 n/a n/a n/a
2025-11-12 2025-09-30 13F APELLIS PHARMACEUTICALS PUT Put 44,400 14.73 1 n/a n/a n/a
2025-08-05 2025-06-30 13F APELLIS PHARMACEUTICALS PUT Put 38,700 -20.21 1 -100.00 n/a n/a n/a
2025-05-12 2025-03-31 13F APELLIS PHARMACEUTICALS PUT Put 48,500 12.27 1 0.00 n/a n/a n/a
2025-02-11 2024-12-31 13F APELLIS PHARMACEUTICALS PUT Put 43,200 -58.66 1 -66.67 n/a n/a n/a
2024-11-08 2024-09-30 13F APELLIS PHARMACEUTICALS PUT Put 104,500 95.69 3 50.00 n/a n/a n/a
2024-07-25 2024-06-30 13F APELLIS PHARMACEUTICALS PUT Put 53,400 -22.27 2 -50.00 n/a n/a n/a
2024-04-25 2024-03-31 13F APELLIS PHARMACEUTICALS PUT Put 68,700 -41.18 4 -33.33 n/a n/a n/a
2024-02-02 2023-12-31 13F APELLIS PHARMACEUTICALS PUT Put 116,800 -47.79 7 -25.00 n/a n/a n/a
2023-11-01 2023-09-30 13F APELLIS PHARMACEUTICALS PUT Put 223,700 11.57 9 -55.56 n/a n/a n/a
2023-08-04 2023-06-30 13F APELLIS PHARMACEUTICALS PUT Put 200,500 86.51 18 157.14 n/a n/a n/a
2023-04-27 2023-03-31 13F APELLIS PHARMACEUTICALS PUT Put 107,500 73.95 7 133.33 n/a n/a n/a
2023-02-02 2022-12-31 13F APELLIS PHARMACEUTICALS PUT Put 61,800 -5.94 3 -99.93 n/a n/a n/a
2022-11-04 2022-09-30 13F APELLIS PHARMACEUTICALS PUT Put 65,700 265.00 4,487 451.91 n/a n/a n/a
2022-08-03 2022-06-30 13F APELLIS PHARMACEUTICALS PUT Put 18,000 -48.57 813 -54.27 n/a n/a n/a
2022-05-02 2022-03-31 13F APELLIS PHARMACEUTICALS PUT Put 35,000 1,066.67 1,778 1,160.99 n/a n/a n/a
2022-02-23 2021-12-31 13F/A APELLIS PHARMACEUTICALS PUT Put 3,000 -41.18 141 -59.13 n/a n/a n/a
2022-02-04 2021-12-31 13F APELLIS PHARMACEUTICALS PUT Put 5,100 345 n/a n/a n/a
2021-10-28 2021-09-30 13F APELLIS PHARMACEUTICALS PUT Put 5,100 2.00 345 9.18 n/a n/a n/a
2021-08-12 2021-06-30 13F APELLIS PHARMACEUTICALS PUT Put 5,000 6,393.51 316 -4.24 n/a n/a n/a
2021-04-26 2021-03-31 13F APELLIS PHARMACEUTICALS PUT Put 77 -84.99 330 4.43 n/a n/a n/a
2021-02-02 2020-12-31 13F APELLIS PHARMACEUTICALS PUT Put 513 51,200.00 0 -100.00 n/a n/a n/a
2020-10-14 2020-09-30 13F APELLIS PHARMACEUTICALS PUT Put 1 -99.40 0 -100.00 n/a n/a n/a
2020-07-13 2020-06-30 13F APELLIS PHARMACEUTICALS PUT Put 166 -53.37 542 -43.13 n/a n/a n/a
2020-04-29 2020-03-31 13F APELLIS PHARMACEUTICALS PUT Put 356 68.72 953 47.52 n/a n/a n/a
2020-02-05 2019-12-31 13F APELLIS PHARMACEUTICALS PUT Put 211 955.00 646 1,245.83 n/a n/a n/a
2019-10-15 2019-09-30 13F APELLIS PHARMACEUTICALS PUT Put 20 48 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.